RalGDS is required for tumor formation in a model of skin carcinogenesis

Cancer Cell

Volumn 7, Issue 3, 2005, Pages 219-226

  González García, Ana ^a   Pritchard, Catrin A ^b   Paterson, Hugh F ^a   Mavria, Georgia ^a   Stamp, Gordon ^c   Marshall, Christopher J ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GUANINE NUCLEOTIDE EXCHANGE FACTOR; GUANOSINE TRIPHOSPHATASE; RAL PROTEIN; RAS PROTEIN; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER INCIDENCE; CANCER STAGING; CELL ISOLATION; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSFORMATION; CONTROLLED STUDY; EMBRYO; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFECT; SIGNAL TRANSDUCTION; SKIN CARCINOGENESIS; SKIN TUMOR; TISSUE CULTURE; TUMOR VOLUME;

EID: 17644408725     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccr.2005.01.029     Document Type: Article

References (51)

1. C. Albanese, J. Johnson, G. Watanabe, N. Eklund, D. Vu, A. Arnold, and R.G. Pestell Transforming p21ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions J. Biol. Chem. 270 1995 23589 23597
2. C.F. Albright, B.W. Giddings, J. Liu, M. Vito, and R.A. Weinberg Characterization of a guanine nucleotide dissociation stimulator for a ras-related GTPase EMBO J. 12 1993 339 347
3. J.M. Arbeit, K. Munger, P.M. Howley, and D. Hanahan Progressive squamous epithelial neoplasia in K14-human papillomavirus type 16 transgenic mice J. Virol. 68 1994 4358 4368
4. Y. Bai, H. Edamatsu, S. Maeda, H. Saito, N. Suzuki, T. Satoh, and T. Kataoka Crucial role of phospholipase Cepsilon in chemical carcinogen-induced skin tumor development Cancer Res. 64 2004 8808 8810
5. B.L. Bennett, D.T. Sasaki, B.W. Murray, E.C. O'Leary, S.T. Sakata, W. Xu, J.C. Leisten, A. Motiwala, S. Pierce, and Y. Satoh SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase Proc. Natl. Acad. Sci. USA 98 2001 13681 13686
6. D.F. Bielinski, H.Y. Pyun, K. Linko-Stentz, I.G. Macara, and R.E. Fine Ral and Rab3a are major GTP-binding proteins of axonal rapid transport and synaptic vesicles and do not redistribute following depolarization stimulated synaptosomal exocytosis Biochim. Biophys. Acta 1151 1993 246 256
7. A. Brymora, V.A. Valova, M.R. Larsen, B.D. Roufogalis, and P.J. Robinson The brain exocyst complex interacts with RalA in a GTP-dependent manner: identification of a novel mammalian Sec3 gene and a second Sec15 gene J. Biol. Chem. 276 2001 29792 29797
8. N. Chen, M. Nomura, Q.B. She, W.Y. Ma, A.M. Bode, L. Wang, R.A. Flavell, and Z. Dong Suppression of skin tumorigenesis in c-Jun NH(2)-terminal kinase-2-deficient mice Cancer Res. 61 2001 3908 3912
9. Y. Chien, and M.A. White RAL GTPases are linchpin modulators of human tumour-cell proliferation and survival EMBO Rep. 4 2003 800 806
10. D.R. D'Adamo, S. Novick, J.M. Kahn, P. Leonardi, and A. Pellicer rsc: a novel oncogene with structural and functional homology with the gene family of exchange factors for Ral Oncogene 14 1997 1295 1305
11. H. Davies, G.R. Bignell, C. Cox, P. Stephens, S. Edkins, S. Clegg, J. Teague, H. Woffendin, M.J. Garnett, and W. Bottomley Mutations of the BRAF gene in human cancer Nature 417 2002 949 954
12. K.M. de Bruyn, J. de Rooij, R.M. Wolthuis, H. Rehmann, J. Wesenbeek, R.H. Cool, A.H. Wittinghofer, and J.L. Bos RalGEF2, a pleckstrin homology domain containing guanine nucleotide exchange factor for Ral J. Biol. Chem. 275 2000 29761 29766
13. N.D. de Ruiter, R.M. Wolthuis, H. van Dam, B.M. Burgering, and J.L. Bos Ras-dependent regulation of c-Jun phosphorylation is mediated by the Ral guanine nucleotide exchange factor-Ral pathway Mol. Cell. Biol. 20 2000 8480 8488
14. L.A. Feig, T. Urano, and S. Cantor Evidence for a Ras/Ral signaling cascade Trends Biochem. Sci. 21 1996 438 441
15. T. Goi, G. Rusanescu, T. Urano, and L.A. Feig Ral-specific guanine nucleotide exchange factor activity opposes other Ras effectors in PC12 cells by inhibiting neurite outgrowth Mol. Cell. Biol. 19 1999 1731 1741
16. N.M. Hamad, J.H. Elconin, A.E. Karnoub, W. Bai, J.N. Rich, R.T. Abraham, C.J. Der, and C.M. Counter Distinct requirements for Ras oncogenesis in human versus mouse cells Genes Dev. 16 2002 2045 2057
17. H. Hennings, A.B. Glick, D.T. Lowry, L.S. Krsmanovic, L.M. Sly, and S.H. Yuspa FVB/N mice: an inbred strain sensitive to the chemical induction of squamous cell carcinomas in the skin Carcinogenesis 14 1993 2353 2358
18. D.O. Henry, S.A. Moskalenko, K.J. Kaur, M. Fu, R.G. Pestell, J.H. Camonis, and M.A. White Ral GTPases contribute to regulation of cyclin D1 through activation of NF-kappaB Mol. Cell. Biol. 20 2000 8084 8092
19. P. Hess, G. Pihan, C.L. Sawyers, R.A. Flavell, and J. Davis Survival signaling mediated by c-Jun NH(2)-terminal kinase in transformed B lymphoblasts Nat. Genet. 32 2002 201 205
20. F. Hofer, R. Berdeaux, and G.S. Martin Ras-independent activation of Ral by a Ca(2+)-dependent pathway Curr. Biol. 8 1998 839 842
21. S.C. Hsu, C.D. Hazuka, D.L. Foletti, and R.H. Scheller Targeting vesicles to specific sites on the plasma membrane: the role of the sec6/8 complex Trends Cell Biol. 9 1999 150 153
22. H. Jiang, J.Q. Luo, T. Urano, P. Frankel, Z. Lu, D.A. Foster, and L.A. Feig Involvement of Ral GTPase in v-Src-induced phospholipase D activation Nature 378 1995 409 412
23. S.A. Johnson, N. Mandavia, H.D. Wang, and D.L. Johnson Transcriptional regulation of the TATA-binding protein by Ras cellular signaling Mol. Cell. Biol. 20 2000 5000 5009
24. G.J. Kops, N.D. de Ruiter, A.M. De Vries-Smits, D.R. Powell, J.L. Bos, and B.M. Burgering Direct control of the Forkhead transcription factor AFX by protein kinase B Nature 398 1999 630 634
25. S. Lebreton, L. Boissel, and J. Moreau Control of embryonic Xenopus morphogenesis by a Ral-GDS/Xral branch of the Ras signalling pathway J. Cell Sci. 116 2003 4651 4662
26. A. Lin Activation of the Jnk signalling pathway: breaking the break on apoptosis Bioessays 25 2003 17 24
27. T. Linnemann, C. Kiel, P. Herter, and C. Herrmann The activation of RalGDS can be achieved independently of its Ras binding domain. Implications of an activation mechanism in Ras effector specificity and signal distribution J. Biol. Chem. 277 2002 7831 7837
28. A. Malliri, R.A. van der Kammen, K. Clark, M. van der Valk, F. Michiels, and J.G. Collard Mice deficient in the Rac activator Tiam1 are resistant to Ras-induced skin tumours Nature 417 2002 867 871
29. R.J. Moore, D.M. Owens, G. Stamp, C. Arnott, F. Burke, N. East, H. Holdsworth, L. Turner, B. Rollins, and M. Pasparakis Mice deficient in tumor necrosis factor-alpha are resistant to skin carcinogenesis Nat. Med. 5 1999 828 831
30. S. Moskalenko, D.O. Henry, C. Rosse, G. Mirey, J.H. Camonis, and M.A. White The exocyst is a Ral effector complex Nat. Cell Biol. 4 2002 66 72
31. H. Murai, M. Ikeda, S. Kishida, O. Ishida, M. Okazaki-Kishida, Y. Matsuura, and A. Kikuchi Characterization of Ral GDP dissociation stimulator-like (RGL) activities to regulate c-fos promoter and the GDP/GTP exchange of Ral J. Biol. Chem. 272 1997 10483 10490
32. S. Nakashima, K. Morinaka, S. Koyama, M. Ikeda, M. Kishida, K. Okawa, A. Iwamatsu, S. Kishida, and A. Kikuchi Small G protein Ral and its downstream molecules regulate endocytosis of EGF and insulin receptors EMBO J. 18 1999 3629 3642
33. M. Quintanilla, K. Brown, M. Ramsden, and A. Balmain Carcinogen-specific mutation and amplification of Ha-ras during mouse skin carcinogenesis Nature 322 1986 78 80
34. A. Rangarajan, S.J. Hong, A. Gifford, and R.A. Weinberg Species- and cell type-specific requirements for cellular tranformation Cancer Cell 6 2004 171 183
35. G.A. Repasky, E.J. Chenette, and C.J. Der Renewing the conspiracy theory debate: does Raf function alone to mediate Ras oncogenesis? Trends Cell Biol. 14 2004 639 647
36. A.I. Robles, M.L. Rodriguez-Puebla, A.B. Glick, C. Trempus, L. Hansen, P. Sicinski, R.W. Tennant, R.A. Weinberg, S.H. Yuspa, and C.J. Conti Reduced skin tumor development in cyclin D1-deficient mice highlights the oncogenic ras pathway in vivo Genes Dev. 12 1998 2469 2474
37. P. Rodriguez-Viciana, P.H. Warne, A. Khwaja, B.M. Marte, D. Pappin, P. Das, M.D. Waterfield, A. Ridley, and J. Downward Role of phosphoinositide 3-OH kinase in cell transformation and control of the actin cytoskeleton by Ras Cell 89 1997 457 467
38. M. Rosario, H.F. Paterson, and C.J. Marshall Activation of the Ral and phosphatidylinositol 3′ kinase signaling pathways by the ras-related protein TC21 Mol. Cell. Biol. 21 2001 3750 3762
39. K. Sawamoto, P. Winge, S. Koyama, Y. Hirota, C. Yamada, S. Miyao, S. Yoshikawa, M.H. Jin, A. Kikuchi, and H. Okano The Drosophila Ral GTPase regulates developmental cell shape changes through the Jun NH(2)-terminal kinase pathway J. Cell Biol. 146 1999 361 372
40. H. Shao, and D.A. Andres A novel RalGEF-like protein, RGL3, as a candidate effector for rit and Ras J. Biol. Chem. 275 2000 26914 26924
41. D.A. Tuveson, A.T. Shaw, N.A. Willis, D.P. Silver, E.L. Jackson, S. Chang, K.L. Mercer, R. Grochow, H. Hock, and D. Crowley Endogenous oncogenic K-ras(G12D) stimulates proliferation and widespread neoplastic and developmental defects Cancer Cell 5 2004 375 387
42. T. Urano, R. Emkey, and L.A. Feig Ral-GTPases mediate a distinct downstream signaling pathway from Ras that facilitates cellular transformation EMBO J. 15 1996 810 816
43. M. van Hogerlinden, B.L. Rozell, L. Ahrlund-Richter, and R. Toftgard Squamous cell carcinomas and increased apoptosis in skin with inhibited Rel/nuclear factor-kappaB signaling Cancer Res. 59 1999 3299 3303
44. Y. Ward, W. Wang, E. Woodhouse, I. Linnoila, L. Liotta, and K. Kelly Signal pathways which promote invasion and metastasis: critical and distinct contributions of extracellular signal-regulated kinase and Ral-specific guanine exchange factor pathways Mol. Cell. Biol. 21 2001 5958 5969
45. M.A. White, C. Nicolette, A. Minden, A. Polverino, L. Van Aelst, M. Karin, and M.H. Wigler Multiple Ras functions can contribute to mammalian cell transformation Cell 80 1995 533 541
46. L. Wojnowski, A.M. Zimmer, T.W. Beck, H. Hahn, R. Bernal, U.R. Rapp, and A. Zimmer Endothelial apoptosis in Braf-deficient mice Nat. Genet. 16 1997 293 297
47. L. Wojnowski, L.F. Stancato, A.M. Zimmer, H. Hahn, T.W. Beck, A.C. Larner, U.R. Rapp, and A. Zimmer Craf-1 protein kinase is essential for mouse development Mech. Dev. 76 1998 141 149
48. R.M. Wolthuis, and J.L. Bos Ras caught in another affair: the exchange factors for Ral Curr. Opin. Genet. Dev. 9 1999 112 117
49. R.M. Wolthuis, B. Bauer, L.J. van 't Veer, A.M. de Vries-Smits, R.H. Cool, M. Spaargaren, A. Wittinghofer, B.M. Burgering, and J.L. Bos RalGDS-like factor (Rlf) is a novel Ras and Rap 1A-associating protein Oncogene 13 1996 353 362
50. R.M. Wolthuis, N.D. de Ruiter, R.H. Cool, and J.L. Bos Stimulation of gene induction and cell growth by the Ras effector Rlf EMBO J. 16 1997 6748 6761
51. R.M. Wolthuis, B. Franke, M. van Triest, B. Bauer, R.H. Cool, J.H. Camonis, J.W. Akkerman, and J.L. Bos Activation of the small GTPase Ral in platelets Mol. Cell. Biol. 18 1998 2486 2491